DuyKhanh P. Ceppa, MD, Ian J. Welsby, MBBS, Tracy Y. Wang, MD, Mark W

Slides:



Advertisements
Similar presentations
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Advertisements

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R
Giant Transdiaphragmatic Intercostal Hernia
Manuel Caceres, MD, Darryl S. Weiman, MD, JD 
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C
Fred H. Edwards, MD, David M. Shahian, MD, Maria V
One or Two Internal Thoracic Grafts
Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery  Itzhak Herz, MD, Yaron Moshkovitz, MD,
Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Spiral Tracheoplasty After Tangential Resection of Trachea
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery  Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,
Peter K. Smith, MD  The Annals of Thoracic Surgery 
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
Sameer A. Hirji, BS, John C. Haney, MD, Ian Welsby, MD, Frederick W
Which Arterial Conduit
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction  P.-G. Chassot, A. Delabays, D.R. Spahn 
Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease?  Jae-Sung Choi, MD, PhD,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Ergun Demirsoy, MD, Kamil Umut Sarkislali, MD 
Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients  Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.
How I Teach a Thoracoscopic Lobectomy
Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Anthony Lemaire, MD, William R
A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer  Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Surgical Resection of a Giant Coronary Aneurysm
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Who Do You Say You Are? The Annals of Thoracic Surgery
Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis  Suvitesh.
Kevin L. Anderson, MHSc, Michael S. Mulvihill, MD, Paul J
Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis  Michael E. Halkos, MD, S. Tanveer.
Use of Amiodarone After Major Lung Resection
Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease  Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,
Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L
Minimally Invasive Direct Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Stenosis:
Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database  Mark Onaitis,
Patient Preferences in Treatment Choices for Early-Stage Lung Cancer
Influence of Diabetes Mellitus on Long-Term Survival in Systematic Off-Pump Coronary Artery Bypass Surgery  Bertrand Marcheix, MD, Frédéric Vanden Eynden,
Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Mark F. Berry, MD, Chi-Fu Jeffrey.
Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease  Noam Fink, MD, Eugenia Nikolsky, MD, Abid Assali, MD,
Alice Wang, MD, Thomas A. D'Amico, MD, Mark F. Berry, MD 
Editorial Board, January 2010
Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting  Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,
Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation 
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting
Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.
Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds
Specialty Training and Mortality After Esophageal Cancer Resection
First Report on 30-day and Operative Mortality in Risk Model of Isolated Coronary Artery Bypass Grafting in Japan  Noboru Motomura, MD, PhD, Hiroaki Miyata,
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?
Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection  Daniel L. Miller, MD, Gerald A. Helms, MD,
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
Mark I. Block, MD  The Annals of Thoracic Surgery 
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery  Chuntao Wu, MD, PhD, Edward L. Hannan,
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
Presentation transcript:

Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection  DuyKhanh P. Ceppa, MD, Ian J. Welsby, MBBS, Tracy Y. Wang, MD, Mark W. Onaitis, MD, Betty C. Tong, MD, David H. Harpole, MD, Thomas A. D'Amico, MD, Mark F. Berry, MD  The Annals of Thoracic Surgery  Volume 92, Issue 6, Pages 1971-1976 (December 2011) DOI: 10.1016/j.athoracsur.2011.07.052 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Algorithm for perioperative clopidogrel management. Patients who are at lower risk of in-stent thrombosis (coronary stenting more than 3 years before surgery, bare-metal stent [BMS] more than 1 year with no history of acute myocardial infarction [AMI]) proceed to surgery on aspirin (acetylsalicylic acid [ASA])after a 5-day period of clopidogrel cessation. Patients who are at higher risk of in-stent thrombosis (drug-eluting stent [DES] less than 12 months, drug-eluting stent more than 12 months who have high-risk clinical factors—renal insufficiency, critical location, off-label placement of coronary stent) are bridged to surgery with an eptifibatide infusion after 3 days of clopidogrel cessation. (DM = diabetes mellitus; EF = ejection fraction; PCI = percutaneous coronary intervention.) The Annals of Thoracic Surgery 2011 92, 1971-1976DOI: (10.1016/j.athoracsur.2011.07.052) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions